Skip to content
Saturday, May 24, 2025
Latest:
  • Not all risk is in the OR: How frailty and nutrition shape nephrectomy outcomes
  • FROM THE LABS: Measles virus detected in Houston wastewater before cases were reported
  • School of Medicine 2025 Class President reflects on medical school journey
  • How trauma impacts healing: one surgeon’s quest to prevent complications
  • Let-7 is key to keep pulmonary fibrosis in check
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
From The Labs

Immune checkpoint therapy for ER+ breast cancers, a missed opportunity?

December 5, 2019 endocrine treatment resistant breast cancer,  ER+ breast cancer,  immune check points,  luminal A breast cancer,  luminal B breast cancer,  Research

In the United States, apart from some forms of skin cancer, breast cancer is the most common cancer in women. It is also the most

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951